Amgen 2nd-quarter profit tops Street view, raises 2016 forecast

July 27 (Reuters) - Amgen Inc on Wednesday reported higher-than-expected second-quarter profit on increased sales of its blockbuster rheumatoid arthritis drug Enbrel and newer medicines, and the company again raised its full-year forecast.